← Back to patent-cliff list
马来酸氯苯那敏
Tier C — Watch / tradeChlorphenamine Maleate
Schering Pharma
Originator
1949
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：HRH1
Brand：Chlor-Trimeton、Haynon、Piriton、Chlo-Amine
Indications (approved)：超敏反应、季节性过敏性鼻炎、皮炎、荨麻疹、瘙痒症、药疹
Regional status
US
临床一期
2011-04-01
EU
-
China
批准上市
1981-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Chlorphenamine Maleate?
Approved indications include: 超敏反应, 季节性过敏性鼻炎, 皮炎, 荨麻疹, 瘙痒症, 药疹.
When does the Chlorphenamine Maleate patent expire?
No public expiry year is available for Chlorphenamine Maleate yet; this page updates once verified.
How do I get a quote for Chlorphenamine Maleate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25